Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04814537 · ClinicalTrials.gov registry record · Phase 4
Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques
A Phase 4 study of Analgesia and Labor Pain, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04814537 is a Phase 4 study of Analgesia and Labor Pain that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 100 participants, above the 88-participant average among 19 other Analgesia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04814537, a Phase 4 study of Analgesia and Labor Pain, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.
Conditions Studied
Interventions
- DRUG Bupivacaine Hydrochloride
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-02-25 |
| Est. Completion | 2022-03-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04814537
The ClinicalTrials.gov registry entry for NCT04814537 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 19 other Analgesia trials with a reported enrollment target (14% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Analgesia appearing as the primary indexed condition, and to 1 intervention - of which Bupivacaine Hydrochloride is the first listed.
NCT04814537 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04814537 about?
NCT04814537 is a clinical study titled "Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques". To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.
What is the current status of trial NCT04814537?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2021-02-25. Estimated completion is 2022-03-23.
What conditions does trial NCT04814537 study?
This clinical trial studies the following conditions: Analgesia, Labor Pain.
What interventions are being tested in trial NCT04814537?
The interventions under investigation include: Bupivacaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT04814537?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04814537 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Analgesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
RECRUITING · Phase 4
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
TAP-patients With Robotic Assisted Lap Prostatectomy
COMPLETED · Phase 4
-
Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.